Clinical trials
Neoplasms clinical trials
Below are recruiting neoplasms clinical trials, each written for real people, not researchers. We’re tracking 1,691 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06403540Recruiting
Pain relief after belly surgery and diaphragm function
This study looks at how different pain relief methods after major abdominal surgery affect the diaphragm, a muscle that helps you breathe. It may help doctors choose the best way to manage pain while protecting your breathing.
IstanbulAges 18 years+ - NCT06412172Recruiting
Natural history study of lung papillomatosis
This study is for people with HPV-related recurrent respiratory papillomatosis (RRP) that has spread to the lungs. Doctors will follow your health over time and study the condition to learn more about how it progresses.
New Haven, ConnecticutAges 18–99 - NCT06417710Recruiting
Standardized check-up for leptomeningeal metastasis
This study watches and writes down how patients with cancer that has spread to the brain or spinal cord lining (leptomeningeal metastases) are doing. It helps doctors learn more about this condition without giving any new treatments.
Houston, TexasAges 18 years+ - NCT06421142Recruiting
FAPI and FDG scans for bladder cancer
This trial is testing if two types of PET/MRI scans (one using FAPI tracer, another using FDG tracer) are better at finding and evaluating muscle-invasive bladder cancer. It may help doctors decide the best treatment for you.
Fuzhou, FujianAges 18–80 - NCT06421285Recruiting
Exercise before breast cancer surgery to prevent lymphedema
This trial tests whether doing exercise before surgery can help prevent arm swelling (lymphedema) in women being treated for breast cancer. If you are newly diagnosed, facing chemotherapy first, and can exercise safely, this study might be a good fit.
Seoul, Seoul Special CityAges 20–80 - NCT06422533Recruiting
Comparing Two Antibiotics for Blood Infection in Cancer Patients
This trial compares two antibiotics (ceftolozane/tazobactam vs. piperacillin/tazobactam) for treating a bloodstream infection in people with blood cancer who have a very low white blood cell count and a fever. The goal is to see which antibiotic works better.
Mexico City, TlalpanAges 18 years+ - NCT06431594RecruitingPhase 1
Study of a new drug for advanced solid tumors
This trial tests a new drug called Mocertatug Rezetecan for people with advanced solid tumors that have stopped responding to standard treatments. It targets a protein called B7-H4 on cancer cells to try to slow or shrink the tumor.
Birmingham, AlabamaAges 18 years+ - NCT06433349Recruiting
How cancer affects family health
This study looks at how cancer affects the whole family. If you or a loved one is being treated for certain cancers with the goal of a cure, researchers want to learn how to best support families during this time.
Odense CAges 18 years+ - NCT06438250RecruitingEarly Phase 1
Studying a new imaging agent for solid tumors
This trial tests a new imaging agent called 68Ga-JH04 that is used with a PET/CT scan. The goal is to see how the agent travels through the body and how much radiation it gives off, which may help doctors better understand and treat your tumor.
Fuzhou, FujianAges 18 years+ - NCT06440616Recruiting
Spectral CT scans for lung cancer detection
This trial is testing a new way to look at CT scans (called spectral imaging) to see if it can better detect lung cancer in people who are suspected of having it. If you are being referred for lung cancer testing, this study may help doctors get clearer information from your scans.
Herlev, Capital RegionAges Any age - NCT06442215Recruiting
Choosing the best surgery for rectal cancer
This trial compares surgical techniques for removing rectal cancer (anterior resection). It looks at patients with adenocarcinoma who are scheduled for surgery to find the best approach.
GironaAges 18 years+ - NCT06443645Recruiting
Protecting the heart during breast cancer treatment
This trial tests whether a diabetes medicine (SGLT2 inhibitor) can prevent heart damage caused by a common chemotherapy drug (anthracycline) in people with early-stage breast cancer. If you are newly diagnosed and about to start chemotherapy or have surgery, this study may be for you.
StrasbourgAges 18 years+ - NCT06449937Recruiting
Local liver treatment for colorectal cancer that has spread
This trial tests whether treating liver tumors with surgery or ablation can help people whose colorectal cancer has spread to the liver and other organs. It may be an option if you've had only 1 or 2 types of chemotherapy and your non-liver metastases are stable.
Chuzhou, AnhuiAges 18–80 - NCT06451211RecruitingPhase 2
Immuno-chemo before surgery for thick or large stomach cancers
This trial tests a combination of immunotherapy and chemotherapy given before surgery to shrink stomach cancers that are particularly thick or large. It aims to see if this approach can make these hard-to-treat tumors easier to remove and improve outcomes.
Guangzhou, GuangdongAges 18–75 - NCT06462664Recruiting
Monocytes and myeloproliferative neoplasms study
This study looks at how a type of white blood cell (monocyte) affects myeloproliferative neoplasms, a group of blood cancers. It aims to help doctors better understand these diseases and improve treatment.
BrestAges 18 years+ - NCT06464913RecruitingPhase 2
Chest wall radiation omission after breast implant reconstruction
This study tests whether skipping chest wall radiation after breast implant reconstruction is safe and effective for patients with stage T1-2N1 breast cancer. It may help avoid side effects from radiation while still controlling the cancer.
Hangzhou, ZhejiangAges 18–70 - NCT06466096Recruiting
Thinking and memory after stomach/colon cancer surgery
This study looks at how older adults (65+) think and remember after surgery for gastrointestinal cancer. It compares those who have temporary confusion after surgery with those who don't, to understand long-term changes in brain function.
BeijingAges 65–100 - NCT06467097RecruitingPhase 3
Drug therapy vs. drug therapy plus radiation for limited kidney cancer
This trial tests whether adding radiation to standard drug therapy helps control kidney cancer that has spread to a few spots (oligometastatic). It is for people with clear cell renal cell carcinoma who have up to 5 metastases.
SeoulAges 20–80 - NCT06468124Recruiting
Testing treatments on mini tumors for breast cancer that has spread
This trial uses a special lab technique (called organoids) to grow a mini version of your tumor from a biopsy sample. Researchers will test different treatments on these mini-tumors to see which one might work best for you.
LondonAges 18 years+ - NCT06475937RecruitingPhase 1
DM001 for advanced solid tumors study
This study tests an experimental drug called DM001 for people with certain advanced cancers (breast, lung, stomach, gastroesophageal, or colorectal) that have not responded to or are not helped by standard treatments. The goal is to see if the drug is safe and how it affects the tumors.
Nashville, TennesseeAges 18 years+ - NCT06476678Recruiting
Testing a new ablation knife for esophageal growths
This study tests a new tool that uses radiofrequency energy to remove precancerous growths from the esophagus. It may be an option if you have a surface-level polyp in your esophagus that hasn't been treated before.
Houston, TexasAges 18 years+ - NCT06477549RecruitingPhase 2
Comparing Two Drug Combinations for Stem Cell Transplant
This study compares two different drug combinations (BeFluBu and FluBuRux) used before a stem cell transplant from a half-matched (haploidentical) donor. The goal is to see which combination works better to prepare your body for the transplant and control your blood cancer.
Saint PetersburgAges 18–75 - NCT06479070Recruiting
Using ctDNA to guide radiotherapy for head and neck cancer
This study looks at whether measuring a DNA fragment in the blood (called ctDNA) can help predict how well radiotherapy works for head and neck cancer. It may help doctors better tailor treatment for patients with stage III or IV disease.
Caen, CaenAges 18 years+ - NCT06481449Recruiting
Radiation therapy for upper esophageal cancer real-world study
This trial is studying standard radiation therapy for people with esophageal cancer in the neck or upper chest (cervical and upper thoracic). It includes those who cannot or choose not to have surgery, and it aims to gather real-world results to improve treatment.
Shijiazhuang, HebeiAges 18 years+
Hear when a new Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neoplasms?
- Yes. Clin2 currently lists 1,691 recruiting neoplasms studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neoplasms trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neoplasms trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.